1.Alleviation of Symptoms by Palliative Care Team in Two Cancer Patients Receiving Chemotherapy
Hiroaki SHIBAHARA ; Natsuko UEMATSU ; Sanae KINOSHITA ; Kaori MANO ; Masahiro AOYAMA ; Satoshi KOBAYASHI ; Kenji TAKAGI ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2011;60(1):31-36
One patient was intervened by our palliative care team (PCT) to relieve neuropathic pain due to postoperative recurrence of rectal cancer. The dosage controlled-release oxycodone was increased, analgesic adjuvant drugs were changed and the administration of betamethasone were started. Furthermore, the number of times the patient took controlled-release oxycodone increased two to three times a day. These changes in medication resulted in relief of symptoms. Cetuximab therapy was given twice during the course. The other patient was intervened by the PCT for right upper limb pain and dyspnea due to postoperative recurrence of breast cancer. Morphine sulfate hydrate and analgesic adjuvant were additionally given. As pain increased three days after the administeration of transdermal fentanyl patches, the patches were changed every other day, instead of every three days. FEC100 therapy was given twice during the course. In the present two cases, the PCT was intervened with great zeal and rapid relief of symptoms resulted. In the meantime chemotherapy proceeded uneventfully. We thought that trust of the chief doctor in the PCT was most important for effective intervention.
2.Success in Pain Management by Switch from Gabapentin to Pregabalin: A Case of Lung Cancer
Hiroaki SHIBAHARA ; Eri IMAI ; Natsuko UEMATSU ; Sanae KINOSHITA ; Kaori MANO ; Ayako YAMAMOTO ; Masahiro AOYAMA ; Daisaku NISHIMURA
Journal of the Japanese Association of Rural Medicine 2011;60(2):104-108
The patient was a woman in her 80s, who was referred to the palliative care team in our hospital for pain due to bone metastases from lung cancer. Although gabapentin and ifenprodil tartrate were administrated in addition to opioids and loxoprofen sodium, and the dose of opioids was increased, pain was not relieved remarkably. A switch from gabapentin to pregabalin brought remarkable pain relief. Before the internal use of pregabalin, the patient was often seen lyiing in bed because of pain. However, by pregabalin, she began to walk, pushing her wheelchair and smile often. Her ability to perform the basic activities of daily living was improved. The switch from gabapentin to pregabalin was one effective option when an analgesic adjuvant for cancer pain was chosen.
3.Successful Pain Control in Cancer Patient on Palliative Therapy by Partial Opioid Rotation
Natsuko UEMATSU ; Hiroaki SHIBAHARA ; Taeko OKAMOTO ; Sanae KINOSHITA ; Kaori MANO ; Masahiro AOYAMA ; Daisaku NISHIMURA ; Akira ITO ; Atsushi YOSHIDA
Journal of the Japanese Association of Rural Medicine 2012;60(6):764-769
Our palliative care team intervened in a patient with sciatica resulting from metastasis to sacral bone after surgery for rectal cancer. Rapid pain control and a change in the route of rescue drug administration from the stoma were needed. Partial opioid rotation was performed. The dose of 25.2 mg in 72 hours in a transdermal fentanyl patch decreased to 16.8 mg in 72 hours, and the dose of 3.6mg in an hour by continuous intravenous injection of morphine was added. The change in the rescue root to intravenous administration by a patient-controlled analgesia pump gave the patient relief from his pain. He was able to attend his daughter's wedding. His family were all pleased with the relief provided. The advantages of this partial opioid rotation are summed up in the following three points: (1) The required time is relatively short; (2) It can be expedient for analgesia due to the addition of different opioids; and (3) The partial opioid rotation produces fewer adverse effects than a full opioid rotation. Adjustment of the amount of drugs for pain relief in cancer patients is important with the situations of the patient and the family taken into consideration fully.
4.Survey of the Use of Macrolide Therapy for Pediatric Otolaryngology Patients on the Basis of Prescription Information and Literature Review
Yasunari Mano ; Yoshinori Kato ; Yuko Eto ; Shigemitsu Saito ; Tokue Imanari ; Kaori Ohuchi ; Iori Hirosawa ; Masataka Tajima ; Noboru Shono ; Harumi Yamada ; Mitsuru Ueki ; Hajime Kotaki ; Mariko Asahi
Japanese Journal of Drug Informatics 2013;15(2):71-77
Objective: Macrolide therapy has been recommended as an effective treatment for pediatric otolaryngology patients with conditions such as chronic sinusitis and otitis media with effusion. However, in many cases, a relapse may occur after cessation of treatment. Therefore, patients are compelled to continue taking antibiotics. In this paper, we examined the relationship between the duration of therapy and period to relapse on the basis of prescription information and literature research.
Methods: To evaluate the therapeutic doses, we investigated the clinical doses of erythromycin and clarithromycin used for pediatric patients in a community pharmacy from January 2009 to July 2009. Further, we performed literature searches on the doses of both drugs using Igaku-Chuo-Zasshi databases (from 1983 to 2011) and compared the data obtained with the clinical doses. Accordingly, the oral doses of macrolides were classified as a low dose or normal dose. We analyzed the relationship between the administration period and the cessation period, which was defined as the period from the cessation of the treatment to relapse.
Results: Review of the 17 selected reports and the clinical doses showed that the maximum dose of erythromycin was 15 mg/kg/day and that of clarithromycin was 8 mg/kg/day during therapy. When both cephem or penicillin antibiotics and low-dose macrolides were taken continuously during the administration period, a weak correlation was observed between the administration period and the cessation period.
Conclusion: These results may be useful for the appropriate use of antibiotics and for preventing relapse in pediatric otolaryngology patients.
5.Changes in Degree of Recognition and Understanding of Pharmacy Students and Its Evaluation in Palliative Care Education
Yasunari Mano ; Risa Hitomi ; Remi Tamura ; Yoshinori Kato ; Kaori Ohuchi ; Iori Hirosawa ; Masataka Tajima ; Jun Matsumoto ; Kayoko Maezawa ; Harumi Yamada ; Yasuyuki Momose ; Mariko Asahi
Japanese Journal of Drug Informatics 2015;17(2):100-105
Objective: In this study, we evaluated the change in degree of recognition and understanding of palliative care as pharmacy students’ years advanced.
Methods: A questionnaire survey consisting of 11 items about recognition of narcotics and 27 items about understanding of palliative care was conducted with first- to fifth-year pharmacy students. We divided the questions about the image of narcotics into groups and classified the questions about their knowledge of palliative care into the categories based on some reports.
Results: Among the three groups of questions about the image of narcotics, the degree of “right recognition of narcotics” increased, and those of “wrong recognition of narcotics” and “sense of resistance to narcotics” decreased as pharmacy students’ years advanced. Additionally, questions about their knowledge of palliative care were categorized into three: “basic guidelines for cancer pain relief and methods of narcotic use,” “role of pharmacists in palliative care and support for patients,” and “pharmacologic characteristics of narcotics.” Their degree of understanding of each category increased with an increase in years. Both the recognition of narcotics and understanding of palliative care changed in the fourth- and fifth-grade year students compared to the first-, second-, and third-year ones.
Conclusion: These results suggest that the recognition and understanding of palliative care changed along the same trends as pharmacy students’ years advanced. Therefore, it is important that pharmacy students acquire appropriate knowledge to play an active role in palliative care.